VENTURE BUILDER IN FOCUS: OXFORD SCIENCE ENTERPRISES

Ed Bussey, CEO of Oxford Science Enterprises (OSE), discusses the organization's venture building approach focused on commercializing advanced science and technology from Oxford University. OSE builds companies in areas like AI, quantum, and health tech, ensuring they solve global problems and have billion-pound potential. The strategic partnership with Oxford University provides early access to science and a unique confidentiality agreement. Long-term patient capital and a dedicated team of scientists, entrepreneurs, and investors are crucial to their success. OSE has 120 portfolio companies, including Oxford Ionics, and aims to significantly increase its net asset value by 2030. Bussey highlights Ultromix and Fractile as examples of their innovative ventures. OSE is exploring commercial partnerships, sharing their company-building playbook, and seeking investment opportunities in the Saudi region. They are open to discussions about building ecosystems and investment possibilities.